The U.S. Food and Drug Administration (FDA) has sent a warning letter to Indian company Amanta, formerly Marck Biosciences, for a range of inspection breaches and possible falsification of records. Amanta’s facility in Kheda in the Gujarat region of India, was inspected by the FDA in October and November of 2013 and numerous unsanitary conditions were reported. - See more at: http://www.clinicaspace.com/News/fda-finds-falsified-data-serious-mold-and-decaying
Next time leadership pushes for investment in china and India, let's all say ok
Next time leadership pushes for investment in china and India, let's all say ok